Restless legs syndrome

Journal of Internal Medicine

Volumn 266, Issue 5, 2009, Pages 419-431

  Ekbom, K ^a   Ulfberg, J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Dopamine agonists; Iron deficiency; Periodic limb movements; Restless legs syndrome; Sleep

Indexed keywords

CLONAZEPAM; DOPAMINE RECEPTOR STIMULATING AGENT; GABAPENTIN; GABAPENTIN ENACARBIL; IRON; LEVODOPA; OPIATE; PLACEBO; PRAMIPEXOLE; ROPINIROLE; ROTIGOTINE;

CENTRAL NERVOUS SYSTEM; CHROMOSOME 12Q; CHROMOSOME 14Q; CHROMOSOME 16P; CHROMOSOME 19P; CHROMOSOME 20P; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; CLINICAL TRIAL; DIALYSIS; EVENING DOSAGE; FAMILY HISTORY; GENETIC ASSOCIATION; HUMAN; IRON DEFICIENCY ANEMIA; IRON THERAPY; KIDNEY FAILURE; LEG MOVEMENT; LOW DRUG DOSE; NEUROIMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; REVIEW; RHEUMATIC DISEASE; TREATMENT DURATION;

DOPAMINE AGONISTS; FEMALE; HUMANS; MALE; PREGNANCY; QUALITY OF LIFE; RESTLESS LEGS SYNDROME; SLEEP DISORDERS;

EID: 70349865294     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2009.02159.x     Document Type: Review

References (116)

1. Trenkwalder C, Paulus W, Walters AS. The restless legs syndrome. Lancet Neurol 2005 4 : 465 475.
2. Ekbom KA. Restless legs. Acta Med Scand 1945 158 : 1 123.
3. Ekbom KA. Restless legs syndrome. Neurology 1960 10 : 868 873.
4. Ekbom KA. Asthenia crurum paraesthetica (irritable legs). Acta Med Scand 1944 118 : 197 209.
5. Ekbom KA. Restless legs in blood donors (in Swedish). Läkartidningen 1956 53 : 3098 3103.
6. Critchley M. The pre-dormitum. Rev Neurol 1955 93 : 101 106.
7. Willis T. The London Practice of Physick. London : Thomas Basset and William Crook, 1685.
8. Ekbom K, Ekbom KA. An early Swedish description of restless legs (Huss 1849) (in Swedish). Läkartidningen 1974 71 : 2905 2906.
9. Huss M. Alcoholismus Chronicus Eller Chronisk Alkoholsjukdom. Stockholm : Joh Beckman, 1849.
10. Konofal E, Karroum E, Montplaisir J, Derenne J-P, Arnulf I. Two early descriptions of restless syndrome and periodic leg movements by Boissier de Sauvages (1763) and Gilles de la Tourette (1898). Sleep Med 2009 10 : 586 591. doi :.
11. Lugaresi E, Tassinari CA, Coccagna G, Ambrosetto C. Particularités cliniques et polygraphiques du syndrome d impatiences des membres inférieurs. Rev Neurol 1965 113 : 545 555.
12. Coleman RM. Periodic movements in sleep (nocturnal myoclonus) and restless legs syndrome. In : Guilleminault C, ed. Sleeping and Waking Disorders: Indications and Techniques. Menlo Park, CA : Addison-Wesley, 1982 265 295.
13. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. Sleep Med 2003 4 : 101 119.
14. Walters AS the International Restless Legs Syndrome Study Group. Toward a better definition of the restless legs syndrome. Mov Disord 1995 10 : 634 642.
15. Walters AS the International Restless Legs Syndrome Study Group. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003 4 : 121 132.
16. Hening W, Walters AS, Allen RP, Montplaisir J, Myers A, Ferini-Strambi L. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med 2004 5 : 237 246.
17. Allen RP, Stillman P, Myers A. Physician-diagnosed restless legs syndrome in a large sample of primary medical care patients in western Europe: prevalence and characteristics. Sleep Med 2009 May 21 (Epub ahead of print); doi :.
18. Lavigne GJ, Montplaisir JY. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 1994 17 : 739 743.
19. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000 160 : 2137 2141.
20. Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and morbidity in Augsburg elderly. Neurology 2000 54 : 1064 1068.
21. Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 2004 164 : 196 202.
22. Ulfberg J, Nyström B, Carter N, Edling C. Prevalence of restless legs syndrome among men aged 18-64 years: an association with somatic disease and neuropsychiatric symptoms. Mov Disord 2001 16 : 1159 1163.
23. Ulfberg J, Nyström B, Carter N, Edling C. Restless legs syndrome among working-aged women. Eur Neurol 2001 46 : 17 9.
24. Bjorvatn B, Leissner L, Ulfberg J et al. Prevalence, severity and risk factors of restless legs syndrome in the general adult population in two Scandinavian countries. Sleep Med 2005 6 : 307 312.
25. Tison F, Crochard A, Legér D, Bouée S, Lainey E, El Hasnaoui A. Epidemiology of restless legs syndrome in French adults: a nationwide survey. The INSTANT study. Neurology 2005 65 : 239 246.
26. Sevim S, Dogu O, Camdeviren H et al. Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey. Neurology 2003 61 : 1562 1569.
27. Tan EK, Seah A, See SJ, Lim E, Wong MC, Koh KK. Restless legs syndrome in an Asian population: a study in Singapore. Mov Disord 2001 16 : 577 579.
28. Ekbom KA. Restless legs. In : Vinken PJ, Bruyn GW, eds. Handbook of Clinical Neurology. Amsterdam : North-Holland Publ Company 1970 8 : 311 320.
29. Trenkwalder C, Seidel VC, Gasser T, Oertel WH. Clinical symptoms and possible anticipation in a large kindred of familial restless legs syndrome. Mov Disord 1996 11 : 389 394.
30. Lazzarini A, Walters AS, Hickey K et al. Studies of penetrance and anticipation in five autosomal-dominant restless legs syndrome pedigrees. Mov Disord 1999 14 : 111 116.
31. Ondo WG, Dat Vuong K, Wang Q. Restless legs syndrome in monozygotic twins: clinical correlates. Neurology 2000 55 : 1404 1406.
32. Desai AV, Cherkas LF, Spector TD, Williams AJ. Genetic influences in self-reported symptoms of obstructive sleep apnoea and restless legs: a twin study. Twin Res 2004 7 : 589 595.
33. Winkelmann J, Polo O, Provini F et al. Genetics of restless legs syndrome (RLS): state-of-the-art and future directions. Mov Disord 2007 22 (Suppl 18 S449 58.
34. Winkelmann J, Schormair B, Lichtner P et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 2007 39 : 1000 1006.
35. Pichler I, Hicks AA, Pramstaller PP. Restless legs syndrome: an update on genetics and future perspectives. Clin Genet 2008 73 : 297 305.
36. Winkelmann J, Lichtner P, Schormair B et al. Variants in the neuronal nitric oxide synthase (nNOS, NOS1) gene are associated with restless legs syndrome. Mov Disord 2008 23 : 350 358.
37. Lohmann-Hedrich K, Neumann A, Kleensang A et al. Evidence for linkage of restless legs syndrome to chromosome 9p: are there two distinct loci? Neurology 2008 70 : 686 694.
38. Young JE, Vilarino-Guell C, Lin S-C, Wszolek ZK, Farrer M. Clinical and genetic description of a family with a high prevalence of autosomal dominant restless legs syndrome. Mayo Clin Proc 2009 84 : 134 138.
39. Levchenko A, Montplaisir J-Y, Asselin G et al. Autosomal-dominant locus for restless legs syndrome in French-Canadians on chromosome 16p12.1. Mov Disord 2009 24 : 40 50.
40. Xiong L, Catoire H, Dion P et al. MEIS1 intronic risk haplotype associated with restless legs syndrome affects its mRNA and protein expression levels. Human Mol Gen 2009 18 : 1065 1074.
41. Dasen JS, Tice BC, Brenner-Morton S, Jessell TM. A Hox regulatory network establishes motor neuron pool identity and target-muscle connectivity. Cell 2005 123 : 477 491.
42. Trenkwalder C, Högl B, Winkelmann J. Recent advances in the diagnosis, genetics and treatment of restless legs syndrome. J Neurol 2009 26 : 539 553.
43. Stefansson H, Rye DB, Hicks A et al. A genetic risk factor for periodic limb movements in sleep. N Engl J Med 2007 357 : 639 647.
44. Allen RP, Earley CJ. Defining the phenotype of the restless legs syndrome (RLS) using age-of-symptom-onset. Sleep Med 2000 1 : 11 9.
45. Nordlander NB. Therapy in restless legs. Acta Med Scand 1953 145 : 453 457.
46. Ekbom KA. Restless legs as an early symptom of cancer. Läkartidningen 1955 52 : 1875 1883.
47. OKeeffe ST, Gavin K, Lavan JN. Iron status and restless legs syndrome in the elderly. Age Ageing 1994 23 : 200 202.
48. Ulfberg J, Nystrom B. Restless legs syndrome in blood donors. Sleep Med 2004 5 : 115 118.
49. Tings T, Schettler V, Canelo M, Paulus W, Trenkwalder C. Impact of regular LDL apheresis on the development of restless legs syndrome. Mov Disord 2004 19 : 1072 1075.
50. Tobiasson M, Alyass B, Söderlund S, BirgegÅrd G High prevalence of restless legs syndrome among patients with polycytemia vera treated with venesectio. Med Oncol. 2009 (Epub ahead of print); doi :.
51. Ekbom K. Akroparestesier och restless legs under graviditet. Läkartidningen 1960 57 : 2597 2603.
52. Manconi M, Govoni V, De Vito A et al. Restless legs syndrome and pregnancy. Neurology 2004 63 : 1065 1069.
53. Callaghan N. Restless legs syndrome in uremic neuropathy. Neurology 1966 16 : 359 361.
54. Bhowmik D, Bhatia M, Gupta S, Agarwal SK, Tiwari SC, Dash SC. Restless legs syndrome in hemodialysis patients in India: a case controlled study. Sleep Med 2003 4 : 143 146.
55. Holley JL, Nespor S, Rault R. Characterizing sleep disorders in chronic hemodialysis patients. ASAIO Trans 1991 37 : M456 7.
56. Winkelmann J, Stautner A, Samtleben W, Trenkwalder C. Long-term course of restless legs syndrome in dialysis patients after kidney transplantation. Mov Disord 2002 17 : 1072 1076.
57. Stehlik R, Arvidsson L, Ulfberg J. Restless legs syndrome is common among female patients with fibromyalgia. Eur Neurol 2009 61 : 107 111.
58. Taylor-Gjevre RM, Gjevre JA, Skomro R, Nair B. Restless legs syndrome in a rheumatoid arthritis patient cohort. J Clin Rheumatol 2009 15 : 12 5.
59. Ondo WG. Restless legs syndrome. Curr Neurol Neurosci Rep 2005 5 : 266 274.
60. Ondo W. Secondary restless legs syndrome. In : Ray Chaudhuri K, Odin P, Olanow CW, eds. Restless Legs Syndrome. London, New York : Taylor & Francis, 2004 57.
61. Cervenka S, PÅlhagen SE, Comley RA et al. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. Brain 2006 129 : 2017 2028.
62. Earley CJ, Connor JR, Beard JL, Malechi EA, Epstein DK, Allen RP. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 2000 54 : 1698 1700.
63. Mizuno S, Mihara T, Miyaoka T, Inagahi T, Horiguchi J. CSF iron, ferritin and transferrin levels in restless legs syndrome. J Sleep Res 2005 14 : 43 7.
64. Allen RP, Barker PB, Wehrl F, Song HK, Earley CJ. MRI measurement of brain iron in patients with restless legs syndrome. Neurology 2001 56 : 263 265.
65. Earley CJ, Barker PB, Horska A, Allen RP. MRI-determined regional brain iron concentration in early- and late-onset restless legs syndrome. Sleep Med 2006 7 : 459 461.
66. Walters AS, Ondo WG, Zhu W, Le W. Does the endogenous opiate system play a role in the Restless legs syndrome?: a pilot post-mortem study. J Neurol Sci 2009 279 : 62 5.
67. Allen R, Walters AS, Montplaisir J et al. Restless legs syndrome prevalence and impact. REST general population study. Arch Intern Med 2005 165 : 1286 1292.
68. Gorman CA, Dyck PJ, Pearson JS. Symptoms of restless legs. Arch Intern Med 1965 115 : 155 160.
69. Broman JE, Mallon L, Hetta J. Restless legs syndrome and its relationship with insomnia symptoms and daytime distress: epidemiological survey in Sweden. Psychiatry Clin Neurosci 2008 62 : 472 475.
70. Wesström J, Nilsson S, Sundström-Poromaa I, Ulfberg J. Restless legs syndrome among women: prevalence, co-morbidity and possible relationship to menopause. Climacteric 2008 11 : 422 428.
71. Montplaisir J, Boucher S, Poirier G et al. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 1997 12 : 61 5.
72. Scofield H, Roth T, Drake C. Periodic limb movements during sleep: population prevalence; clinical correlates, and racial differences. Sleep 2008 31 : 1221 1227.
73. Gosselin N, Lanfranchi P, Michaud M et al. Age and gender effects on heart rate activation associated with periodic leg movements in patients with restless legs syndrome. Clin Neurophysiol 2003 114 : 2188 2195.
74. Sforza E, Pichot V, Barthelemy JC, Haba-Rubio J, Roche F. Cardiovascular variability during periodic leg movements: a spectral analysis approach. Clin Neurophysiol 2005 116 : 1096 1104.
75. Pennestri MH, Montplaisir J, Colombo R, Lavigne G, Lanfranchi PA. Nocturnal blood pressure changes in patients with restless legs syndrome. Neurology 2007 68 : 1213 1218.
76. Krystal AD. Treating the health, quality of life, and functional impairments in insomnia. J Clin Sleep Med 2007 3 : 63 72.
77. Garcia-Borreguero D. Time to REST: epidemiology and burden. Eur J Neurol 2006 13 (Suppl 3) : 15 20.
78. Kushida C, Martin M, Nikam P et al. Burden of restless legs syndrome on health-related quality of life. Qual Life Res 2007 16 : 617 624.
79. Cuellar NG, Strumpf NE, Ratcliffe SJ. Symptoms of restless legs syndrome in older adults: outcomes on sleep quality, sleepiness, fatigue, depression, and quality of life. J Am Geriatr Soc 2007 55 : 1387 1392.
80. Banno K, Delaive K, Walld R, Kryger MH. Restless legs syndrome in 218 patients: associated disorders. Sleep Med 2000 1 : 221 229.
81. Picchietti D, Winkelman JW. Restless legs syndrome, periodic limb movements in sleep, and depression. Sleep 2005 28 : 891 898.
82. Hornyak M, Kopasz M, Berger M, Riemann D, Voderholzer U. Impact of sleep-related complaints on depressive symptoms in patients with restless legs syndrome. J Clin Psychiatry 2005 66 : 1139 1145.
83. Pearson VE, Allen RP, Dean T, Gamaldo CE, Lesagne SR, Earley CJ. Cognitive deficits associated with restless legs syndrome (RLS). Sleep Med 2006 7 : 25 30.
84. dOnofrio F, Bussone G, Cologno D et al. Restless legs syndrome and primary headaches: a clinical study. Neurol Sci 2008 29 : S169 72.
85. Winkelman JW, Shahar E, Sharief I, Gottlieb DJ. Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study. Neurology 2008 70 : 35 42.
86. Krieger J, Schroeder C. Iron, brain and restless legs syndrome. Sleep Med Rev 2001 5 : 277 286.
87. Oertel WH, Trenkwalder C, Zucconi M et al. State of the art in restless legs syndrome therapy: practice recommendations for treating restless legs syndrome. Mov Disord 2007 22 (Suppl 18 S466 75.
88. Tunc T, Karadaq YS, Dogulu F, Inan LE. Predisposing factors of restless legs syndrome in pregnancy. Mov Disord 2007 22 : 627 631.
89. Patrick LR. Restless legs syndrome: pathophysiology and the role of iron and folate. Altern Med Rev 2007 12 : 101 112.
90. Akpinar S. Treatment of restless legs syndrome with levodopa plus benserazide. Arch Neurol 1982 39 : 739.
91. von Scheele C. Levodopa in restless legs. Lancet 1986 2 : 426 427.
92. Conti CF, de Oliviera MM, Andriolo RB et al. Levodopa for idiopathic restless legs syndrome: evidence-based review. Mov Disord 2007 22 : 1943 1951.
93. Allen RP, Earley CJ. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 1996 19 : 205 213.
94. Garcia-Borreguero D. Augmentation: understanding a key feature of RLS. Sleep Med 2004 5 : 5 6.
95. Garcia-Borreguero D, Allen RP, Kohnen R et al. Diagnostic standards for dopaminergic augmentation of restless legs syndrome. Sleep Med 2007 8 : 520 530.
96. Trenkwalder C, Högl B, Benes H, Kuhnen R. Augmentation in restless legs syndrome is associated with low ferritin. Sleep Med 2008 9 : 572 574.
97. Montplaisir J, Nicolas A, Denesle R, Gomez-Mancilla B. Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology 1999 52 : 938 943.
98. Winkelman JW, Sethi KD, Kushida CA et al. Efficacy and safety of pramipexole in restless legs syndrome. Neurology 2006 67 : 1034 1039.
99. Partinen M, Hirvonen K, Jama L et al. Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study - the PRELUDE study. Sleep Med 2006 7 : 407 417.
100. Allen R, Becker PM, Bogan R et al. Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome. Sleep 2004 27 : 907 914.
101. Trenkwalder C, Garcia-Borreguero D, Montagna P et al. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry 2004 75 : 92 7.
102. Bogan RK, Fry JM, Schmidt MH, Carson SW, Ritchie SY, for the TREAT RLS US Study Group. Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial. Mayo Clin Proc 2006 81 : 17 27.
103. Montplaisir J, Fantini ML, Desautels A, Michaud M, Petit D, Filipini D. Long-term treatment with pramipexole in restless legs syndrome. Eur J Neurol 2006 13 : 1306 1311.
104. Garcia-Borreguero D, Grunstein R, Sridhar G et al. A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome. Sleep Med 2007 8 : 742 752.
105. Trenkwalder C, Benes H, Poewe W et al. Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2008 7 : 595 604.
106. Happe S, Trenkwalder C. Role of dopamine receptor agonists in the treatment of restless legs syndrome. CNS Drugs 2004 18 : 27 36. (Pubitemid 38197757)
107. Walters AS, Winkelmann J, Trenkwalder C et al. Long-term follow-up on restless legs syndrome patients treated with opioids. Mov Disord 2001 16 : 1105 1109. (Pubitemid 36041223)
108. Trenkwalder C, Hening WA, Montagna P et al. Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice. Mov Disord 2008 23 : 2267 2302.
109. Fulda S, Wetter T. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome. Brain 2008 131 : 902 917.
110. Saletu M, Anderer P, Saletu-Zyhlarz G et al. Restless legs syndrome (RLS) and periodic limb movements disorder (PLMD): acute placebo-controlled sleep laboratory studies with clonazepam. Eur Neuropsychopharmacol 2001 11 : 153 161.
111. Garcia-Borreguero D, Larrosa O, de la Llave Y, Verger K, Masramon X, Hernandez G. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology 2002 59 : 1573 1579.
112. Happe S, Sauter C, Klösch G, Saletu B, Zeitlhofer J. Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome. Neuropsychobiology 2003 48 : 82 6.
113. Kushida CA, Becker PM, Ellenbogen AL, Canafax DM, Barrett RW, for the XP052 Study Group. Randomized, double-blind, placebo-controlled study of XP13512/GSK 1838262 in patients with RLS. Neurology 2009 72 : 439 446.
114. Sloand JA, Shelly MA, Feigin A, Bernstein P, Monk RD. A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome. Am J Kidney Dis 2004 43 : 663 670.
115. Grote L, Leissner L, Hedner J, Ulfberg J. A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome. Mov Disord 2009 24 : 1445 1452.
116. Wang J, OReilly B, Venkataraman R, Mysliwiec V, Mysliwiec A Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: a randomized, double-blind, placebo-controlled study. Sleep Med 2009 (Epub ahead of print); doi :.